Rec-1245
Relapsed/Refractory Lymphomas
Recursion Pharmaceuticals Inc.Phase 1/2
—
Rating in progress
Rec-1245 in Relapsed/Refractory Lymphomas is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active